Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, October 23, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
STORY3 Capital Partners Completes Structured Growth Equity Investment in Renew Anchored Dentures
Life Sciences Times
-
June 11, 2021
0
Venture Capital
Owl Peak Labs Closes Seed Round
Life Sciences Times
-
June 10, 2021
0
Venture Capital
Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology
Life Sciences Times
-
June 9, 2021
0
Venture Capital
Medtech Accelerator Sofinnova MD Start III Launches a Call for Early Stage Medical Device Projects
Life Sciences Times
-
June 8, 2021
0
Venture Capital
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
Life Sciences Times
-
June 3, 2021
0
Venture Capital
Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer
Life Sciences Times
-
June 3, 2021
0
Venture Capital
Blackstone Has Acquired Desotec
Life Sciences Times
-
June 3, 2021
0
Venture Capital
Nayya Raises $37 Million in Series B Growth Capital, co-led by SVB Capital and ICONIQ Growth
Life Sciences Times
-
June 2, 2021
0
Venture Capital
Oxford Finance Provides $24 Million Credit Facility to Lantern Group
Life Sciences Times
-
June 2, 2021
0
Venture Capital
Solesis Completes Investment from Altaris Capital Partners
Life Sciences Times
-
June 1, 2021
0
Venture Capital
Accelerator Life Science Partners’ Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.
Life Sciences Times
-
May 28, 2021
0
Venture Capital
Vetster Raises $12.25M CAD to Revolutionize Global Pet Care Industry
Life Sciences Times
-
May 27, 2021
0
1
...
108
109
110
...
115
Page 109 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026